|
Biogenerics: Challenges and Promise |
|
Biogenerics: Challenges and Promise takes an insightful look at the burgeoning biogenerics industry and helps to clarify the complicated regulations that currently govern biogeneric development in both the US and Europe.
|
|
Read more...
|
|
|
Global Protein Therapeutics: Market Dynamics and Pipeline Analysis |
|
The global protein therapeutics market was valued at US$57 billion in 2005. Biotechnology has made notable inroads in the field of protein therapeutics, resulting in some of the key products presently available in the category.
|
|
Read more...
|
|
Monoclonal Antibodies 2007: Competitive Landscape & Pipeline Insight |
|
In 2005, the antibodies market was valued at an estimated US$14 billion, accounting for over 24 percent of the total protein therapeutics market. This share increased substantially since 2001, when it barely surpassed 13 percent.
|
|
Read more...
|
|
|
|
|
